WHC is still in active development. Read this to understand our approach.
depiction of LBWQSAZEYIZZCE-UHFFFAOYSA-N.svg
isomerdesign

Pexacerfont

Check on isomerdesign

drugmap

Pexacerfont

Check on drugmap

wiki

Pexacerfont

Check on wiki

Data

InChI: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)

Synonyms: 459856-18-9, Pyrazolo[1,5-a]-1,3,5-triazine, 13-15,PEXACERFONT,BMS-562,086, BMS 562086,Pexacerfont, DB12572, BMS562086, BDBM29490, HY-12127, CS-6630, Pyrazolo(1,5-a)-1,3,5-triazin-4-amine, 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-((1R)-1-methylpropyl)-, Pexacerfont (USAN/INN), LF1VBG4ZUK,BMS-562086, DTXSID60196675, SCHEMBL5235999, BMS-562086, CRF1 ANTAGONIST, Pexacerfont [USAN:INN], D10022, CHEMBL482950,BMS 562086, UNII-LF1VBG4ZUK

Estimated data

Solubility: -5.691 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 38.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.